Focus: Purple Biotech is a small-molecule biotech company headquartered in Rehovot, Israel, focused on cardiovascular and oncology therapeutics. The company operates at pre-commercial scale with a marketed cardiovascular product and early-stage oncology pipeline.
Profile data last refreshed 15h ago · AI intelligence enriched 1w ago
Best suited for early-career scientists or commercial professionals willing to take pre-commercial biotech risk for equity upside and hands-on impact in a nascent oncology franchise.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Marketed cardiovascular NDA with 14+ years of patent exclusivity providing near-term revenue foundation and commercial runway.
Help build intelligence for Purple Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Purple Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo